Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer

Oncology Reports

Volumn 30, Issue 4, 2013, Pages 1832-1840

  Chen, Yong ^a   Min, Lingfeng ^a   Zhang, Xizhi ^a   Hu, Suwei ^a   Wang, Buhai ^a   Liu, Wei ^b   Wang, Rui ^c   Gu, Xuewen ^a   Shen, Weigan ^d   Lv, Houning ^d   Zou, Jing ^a   Chen, Yuexiang ^a   Xu, Xingxiang ^a   Chen, Longbang ^c  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

^b Hebei Provincial Tumor Hospital   (China)

^c NANJING UNIVERSITY   (China)

^d YANGZHOU UNIVERSITY   (China)

Author keywords

Clinicopathologic characteristics; Methylation; MiRNA 148a; Non small cell lung cancer; Prognostic value

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE 1; MICRORNA; MICRORNA 148A; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; METASTASIS INHIBITION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE-FREE SURVIVAL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; SURVIVAL; TREATMENT OUTCOME;

EID: 84882658876     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2611     Document Type: Article

References (34)

1. Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin 54: 8-29, 2004.
2. Minna JD, Roth JA and Gazdar AF: Focus on lung cancer. Cancer Cell 1: 49-52, 2002.
3. Dykxhoorn DM: MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 70: 6401-6406, 2010.
4. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
5. Farazi TA, Spitzer JI, Morozov P and Tuschl T: miRNAs in human cancer. J Pathol 223: 102-115, 2011.
6. Garzon R, Fabbri M, Cimmino A, Calin GA and Croce CM: MicroRNA expression and function in cancer. Trends Mol Med 12: 580-587, 2006.
7. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
8. Schetter AJ, Leung SY, Sohn JJ, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008.
9. Hummel R, Hussey DJ, Michael MZ, et al: MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann Surg Oncol 18: 253-260, 2011.
10. Langevin SM, Stone RA, Bunker CH, et al: MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck. Cancer 117: 1454-1462, 2011.
11. Watanabe K, Emoto N, Hamano E, et al: Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer. Int J Cancer 130: 2580-2590, 2012.
12. Visone R, Rassenti LZ, Veronese A, et al: Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 114: 3872-3879, 2009.
13. Magrelli A, Azzalin G, Salvatore M, et al: Altered microRNA expression patterns in hepatoblastoma patients. Transl Oncol 2: 157-163, 2009.
14. Xu Q, Jiang Y, Yin Y, et al: A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol 5: 3-13, 2013.
15. Ueda T, Volinia S, Okumura H, et al: Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11: 136-146, 2010.
16. Katada T, Ishiguro H, Kuwabara Y, et al: microRNA expression profile in undifferentiated gastric cancer. Int J Oncol 34: 537-542, 2009.
17. Chen Y, Song Y, Wang Z, et al: Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 14: 1170-1179, 2010.
18. Zhang H, Li Y, Huang Q, et al: MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ 18: 1702-1710, 2011.
19. Zhu A, Xia J, Zuo J, et al: MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer. Med Oncol 29: 2701-2709, 2012.
20. Liffers ST, Munding JB, Vogt M, et al: MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest 91: 1472-1479, 2011.
21. Lujambio A, Calin GA, Villanueva A, et al: A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105: 13556-13561, 2008.
22. Zheng B, Liang L, Wang C, et al: MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 17: 7574-7583, 2011.
23. Reddel RR, Ke Y, Gerwin BI, et al: Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48: 1904-1909, 1988.
24. Hanoun N, Delpu Y, Suriawinata AA, et al: The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem 56: 1107-1118, 2010.
25. Wang G, Hu X, Lu C, Su C, Luo S and Luo ZW: Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer. Lung Cancer 62: 162-172, 2008.
26. Pan W, Zhu S, Yuan M, et al: MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184: 6773-6781, 2010.
27. Xi Y, Nakajima G, Gavin E, et al: Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 13: 1668-1674, 2007.
28. Zhang X, Chen J, Radcliffe T, Lebrun DP, Tron VA and Feilotter H: An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J Mol Diagn 10: 513-519, 2008.
29. Leite KR, Canavez JM, Reis ST, et al: miRNA analysis of prostate cancer by quantitative real time PCR: comparison between formalin-fixed paraffin embedded and fresh-frozen tissue. Urol Oncol 29: 533-537, 2011.
30. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
31. Calin GA and Croce CM: MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66: 7390-7394, 2006.
32. Qiu X, Qiao F, Su X, Zhao Z and Fan H: Epigenetic activation of E-cadherin is a candidate therapeutic target in human hepatocellular carcinoma. Exp Ther Med 1: 519-523, 2010.
33. Huang J, Wang Y, Guo Y and Sun S: Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 52: 60-70, 2010.
34. Shimamoto T, Ohyashiki JH, Hirano T, Kato H and Ohyashiki K: Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: Potential prognostic implication. Oncol Rep 12: 389-395, 2004.